Directory

>

George Mulligan

avatar

George Mulligan

Chief Scientific Officer | Multiple Myeloma Research Foundation - MMRF

Boston, Massachusetts, United States

View contact details (it's free)

George Mulligan

Summary

George Mulligan is an accomplished Chief Scientific Officer with over 20 years of experience in clinical drug development, specializing in oncology and rare diseases. His extensive background allows him to integrate scientific principles with strategic partnerships to tackle the complexities of developing new therapies. George is passionate about improving patient outcomes and has a track record of leading teams to success in biomarker research and drug development. He has held key leadership roles in several pharmaceutical companies, including Takeda and Mitobridge, where he focused on translational medicine and innovative therapeutic strategies. His academic credentials include a PhD in Cellular and Developmental Biology from Stony Brook University and post-doctoral studies at MIT. George is known for his ability to navigate complex regulatory environments and foster collaboration across multidisciplinary teams. He is committed to advancing the field of pharmaceutical research and is particularly interested in the intersection of science and patient care.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Professional interests

Emerging Technologies

Leadership Development

Organisational experience

Corporate Experience

George Mulligan

Work Experience

company logo

Chief Scientific Officer at

Multiple Myeloma Research Foundation - MMRF

March 2022 - Present

company logo

Chief Development Officer (CDO) at

Bantam Pharmaceutical

October 2021 - March 2022

company logo

Chief Scientific Officer Mitobridge, an Astellas Co. at

Astellas Pharma Global Development, Inc.

July 2020 - December 2020

company logo

Senior Vice President at

Astellas Pharma Global Development, Inc.

October 2015 - May 2020

company logo

Senior Director Translational Medicine at

Takeda Pharmaceuticals America, Inc.

September 2014 - October 2015

company logo

Director Translational Medicine at

Takeda Pharmaceuticals America, Inc.

April 2007 - September 2014

company logo

Senior Scientist at

MILLENNIUM PHARMACEUTICALS, INC.

February 2000 - October 2007

company logo

Senior Research Sceintist at

Aventis

January 1999 - January 2000

company logo

Senior Research Scientist at

Takeda Pharmaceuticals America, Inc.

January 1998 - January 1999

Logos provided by Logo.dev

George Mulligan

Education

MIT Center for Cancer Research, Post-Doctoral Studies

State University of New York- Stony Brook, Doctor Of Philosophy (Phd)

Fordham University, Bachelor Of Science (Bs)

Frequently Asked Questions about George Mulligan

What is George Mulligan email address?

George Mulligan's primary email address is *********@themmrf.org. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does George Mulligan work for?

George Mulligan is a Chief Scientific Officer at Multiple Myeloma Research Foundation - MMRF, a company specializing in Real estate agents & managers.

Where George Mulligan graduated from?

George Mulligan holds a degree in Mouse Models Of Tumor Supporessor And Oncogene Function (Tyler Jacks Lab) from MIT Center for Cancer Research.

How can I directly contact George Mulligan?

To contact George Mulligan directly, you can use the email address *********@themmrf.org. Complete contact information is available upon registration with Muraena.

Who is George Mulligan?

George Mulligan is an accomplished Chief Scientific Officer with over 20 years of experience in clinical drug development, specializing in oncology and rare diseases. His extensive background allows him to integrate scientific principles with strategic partnerships to tackle the complexities of developing new therapies. George is passionate about improving patient outcomes and has a track record of leading teams to success in biomarker research and drug development. He has held key leadership roles in several pharmaceutical companies, including Takeda and Mitobridge, where he focused on translational medicine and innovative therapeutic strategies. His academic credentials include a PhD in Cellular and Developmental Biology from Stony Brook University and post-doctoral studies at MIT. George is known for his ability to navigate complex regulatory environments and foster collaboration across multidisciplinary teams. He is committed to advancing the field of pharmaceutical research and is particularly interested in the intersection of science and patient care.

George`s contact details

mail

*********@themmrf.org

***************@mpi.com

***************@takeda.com

*********@mitobridge.com

Colleagues

avatar
Michael Andreini

President & Chief Executive Officer

avatar
Anne Quinn Young

Rare As One Program Mentor

avatar
Msrc Katie Wozniak

Vice President, Clinical Research

avatar
Christopher Williams

VP Business Development/Alliance Management

avatar
Greg Rubenstein

Vice President, Marketing & Communications

avatar
Hearn Cho

Clinical Professor of Medicine

avatar
W Laforge

Member of Board of Directors, Chair of Risk Committee

View Contact details (it's free)
Request Profile Removal